Vertex Pharmaceuticals Inc. Earnings Rise 216% In Q3

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) revealed a profit for its third quarter that rose from last year.

The company said its bottom line totaled $136 million, or $0.53 per share. This was up from $43 million, or $0.17 per share, in last year's third quarter.

Analysts had expected the company to earn $0.31 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 39.7% to $578.17 million. This was up from $413.78 million last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q3): $136 Mln. vs. $43 Mln. last year. -Earnings Growth (Y-o-Y): 216.3% -EPS (Q3): $0.53 vs. $0.17 last year. -EPS Growth (Y-o-Y): 211.8% -Analysts Estimate: $0.31 -Revenue (Q3): $578.17 Mln vs. $413.78 Mln last year. -Revenue Change (Y-o-Y): 39.7%